India's Zydus Cadila seeks human trial approval for Covid-19 antibody cocktail

India's Zydus Cadila seeks human trial approval for Covid-19 antibody cocktail The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials, the drugmaker said, adding it was found to be safe and well-tolerated. The therapy is a cocktail of two monoclonal antibodies, which mimic natural antibodies that the body generates to fight infection. https://ift.tt/eA8V8J